Secondary analysis of the AVATAR2 trial using experience sampling in 200 voice hearers: extended AVATAR therapy, but not the brief form, reduced momentary voice-related distress at 16 and 28 weeks versus usual care; voice hearing frequency did not change.
Secondary analysisn = 200
Edwards et al. The Impact of AVATAR Therapy on Voice Hearing in Everyday Life: ESM Outcomes of the AVATAR2 Trial